Cancer

News

Sanofi gets opt-in rights to two Regeneron cancer drugs

Sanofi and Regeneron have restructured and extended their immune-oncology discovery and development agreement, giving the French drugmaker rights to opt-in to development and marketing of t

News

AZ appoints controversial doctor to lead new oncology unit

AstraZeneca has a new and controversial oncology head after the departure of two key leaders led to a management reshuffle.

News

Owlstone's ReCIVA is being developed to diagnose lung cancer, but also has applications in precision medicine trials

CRUK and Owlstone launch trial for cancer breath test

Cancer Research UK and Owlstone Medical have launched a clinical trial to develop a breath test that could detect cancer at an early stage – the first test of its kind to investigate multip

News

PureTech's Vedanta raises $27m for microbiome research

US-based Vedanta Biosciences has raised $27 million in a Series C financing to investigate microbiome-derived therapies for several indications, including cancer and

News

FDA extends review of Merck & Co's Keytruda in lung cancer u...

US regulators have pushed back the deadline for their review of Merck & Co’s immunotherapy Keytruda in certain patients with untreated lung cancer, after the pharmaceutical company subm

News

AZ/Merck & Co get new US use for ovarian cancer drug

After several disappointments this year AstraZeneca has ended 2018 on a positive note, gaining a new use for its ovarian cancer drug Lynparza in the US and a first approval in China for its

Sanofi gets opt-in rights to two Regeneron cancer drugs

AZ appoints controversial doctor to lead new oncology unit

CRUK and Owlstone launch trial for cancer breath test

PureTech's Vedanta raises $27m for microbiome research

FDA extends review of Merck & Co's Keytruda in lung cancer u...

AZ/Merck & Co get new US use for ovarian cancer drug

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Cancer

Editor's Picks